The clinical-stage biotech could see its shares plummet should there be any clinical setback.

Organizations have a wealth of unstructured data that most AI models can’t yet read. Preparing and contextualizing this data ...

Osyle introduces a new paradigm for AI by encoding expert judgment and ownership, shifting the future of intelligence from ...